{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:00:28Z","timestamp":1790388028356,"version":"4.1.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2016,11,29]]},"DOI":"10.18632\/aging.101086","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T01:19:53Z","timestamp":1480468793000},"page":"2777-2789","source":"Crossref","is-referenced-by-count":48,"title":["Long-term caloric restriction in ApoE-deficient mice results in neuroprotection via Fgf21-induced AMPK\/mTOR pathway"],"prefix":"10.18632","volume":"8","author":[{"given":"Claire","family":"R\u00fchlmann","sequence":"first","affiliation":[{"name":"Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjark","family":"W\u00f6lk","sequence":"additional","affiliation":[{"name":"Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Bl\u00fcmel","sequence":"additional","affiliation":[{"name":"Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stahn","sequence":"additional","affiliation":[{"name":"Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Vollmar","sequence":"additional","affiliation":[{"name":"Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Kuhla","sequence":"additional","affiliation":[{"name":"Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"1","first-page":"641","article-title":"The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake.","volume":"11","author":"Guthrie","year":"1986","journal-title":"J Nutr"},{"key":"2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.exger.2007.10.011","article-title":"Downregulation of plasma insulin levels and hepatic PPARgamma expression during the first week of caloric restriction in mice.","volume":"4","author":"Saupe","year":"2008","journal-title":"Exp Gerontol"},{"key":"3","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1210\/en.2002-0113","article-title":"Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor.","volume":"14","author":"Mattson","year":"2003","journal-title":"Endocrinology"},{"key":"4","doi-asserted-by":"publisher","first-page":"e68778","DOI":"10.1371\/journal.pone.0068778","article-title":"Lifelong caloric restriction increases working memory in mice.","volume":"8","author":"Wree","year":"2013","journal-title":"PLoS One"},{"key":"5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.neurobiolaging.2004.09.014","article-title":"Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models.","volume":"2","author":"Finch","year":"2005","journal-title":"Neurobiol Aging"},{"key":"6","first-page":"417","article-title":"Calorie restriction attenuates Alzheimer\u2019s disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus).","volume":"1","author":"Pasinetti","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.nbd.2006.12.019","article-title":"Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer\u2019s disease.","volume":"2","author":"Mattson","year":"2007","journal-title":"Neurobiol Dis"},{"key":"8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbr.2007.09.002","article-title":"Food restriction attenuates ischemia-induced spatial learning and memory deficits despite extensive CA1 ischemic injury.","volume":"18","author":"Plamondon","year":"2008","journal-title":"Behav Brain Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1742-2094-11-85","article-title":"Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment.","volume":"1","author":"Kawamoto","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10","doi-asserted-by":"publisher","first-page":"e00065","DOI":"10.7554\/eLife.00065","article-title":"The starvation hormone, fibroblast growth factor-21, extends lifespan in mice.","volume":"1","author":"Mangelsdorf","year":"2012","journal-title":"eLife"},{"key":"11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/gerona\/glt160","article-title":"Lifelong caloric restriction reprograms hepatic fat metabolism in mice.","volume":"6","author":"Vollmar","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.coph.2009.07.001","article-title":"FGFs and metabolism.","volume":"9","author":"Kharitonenkov","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"13","doi-asserted-by":"publisher","first-page":"e33870","DOI":"10.1371\/journal.pone.0033870","article-title":"Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"key":"14","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1101\/gad.266551.115","article-title":"Fibroblast growth factor signaling in skeletal development and disease.","volume":"2","author":"Marie","year":"2015","journal-title":"Genes Dev"},{"key":"15","doi-asserted-by":"publisher","first-page":"e94996","DOI":"10.1371\/journal.pone.0094996","article-title":"Glucagon stimulates hepatic FGF21 secretion through a PKA- and EPAC-dependent posttranscriptional mechanism.","volume":"9","author":"Hillgartner","year":"2014","journal-title":"PLoS One"},{"key":"16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","article-title":"PPARalpha is a key regulator of hepatic FGF21.","volume":"36","author":"Rudling","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.","volume":"5","author":"Maratos-Flier","year":"2007","journal-title":"Cell Metab"},{"key":"18","doi-asserted-by":"publisher","first-page":"901S","DOI":"10.3945\/ajcn.110.001941","article-title":"Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.","volume":"9","author":"Maratos-Flier","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"19","doi-asserted-by":"publisher","first-page":"12553","DOI":"10.1073\/pnas.1006962107","article-title":"Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway.","volume":"10","author":"Gromada","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.mce.2015.09.012","article-title":"Ketogenic diet delays the phase of circadian rhythms and does not affect AMP-activated protein kinase (AMPK) in mouse liver.","volume":"41","author":"Froy","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-012-8173-2","article-title":"Roles of AMP-activated protein kinase in Alzheimer\u2019s disease.","volume":"1","author":"Zhao","year":"2012","journal-title":"Neuromolecular Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","article-title":"mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy.","volume":"8","author":"Butterfield","year":"2015","journal-title":"Neurobiol Dis"},{"key":"23","doi-asserted-by":"publisher","first-page":"e0142340","DOI":"10.1371\/journal.pone.0142340","article-title":"The mTOR inhibitor rapamycin mitigates perforant pathway neurodegeneration and synapse loss in a mouse model of early-stage alzheimer-type tauopathy.","volume":"1","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","article-title":"The fasting polypeptide FGF21 can enter brain from blood.","volume":"2","author":"Kastin","year":"2007","journal-title":"Peptides"},{"key":"25","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.2337\/db11-0672","article-title":"Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.","volume":"6","author":"Randeva","year":"2011","journal-title":"Diabetes"},{"key":"26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11011-015-9789-3","article-title":"Potential roles of fibroblast growth factor 21 in the brain.","volume":"3","author":"Chattipakorn","year":"2016","journal-title":"Metab Brain Dis"},{"key":"27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2193-1801-3-2","article-title":"Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1\u03b1 in human dopaminergic neurons via Sirtuin-1.","volume":"3","author":"Lindholm","year":"2014","journal-title":"Springerplus"},{"key":"28","doi-asserted-by":"publisher","first-page":"15556","DOI":"10.1074\/jbc.M112.435123","article-title":"Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.","volume":"28","author":"Pei","year":"2013","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/00005072-199409000-00002","article-title":"Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease.","volume":"5","author":"Roses","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3940(95)12007-Q","article-title":"Phosphorylation of tau in apolipoprotein E-deficient mice.","volume":"19","author":"Michaelson","year":"1995","journal-title":"Neurosci Lett"},{"key":"31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3940(95)12006-P","article-title":"Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.","volume":"19","author":"Michaelson","year":"1995","journal-title":"Neurosci Lett"},{"key":"32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/156720512799015064","article-title":"Metabolic dysfunction in Alzheimer\u2019s disease and related neurodegenerative disorders.","volume":"9","author":"Martin","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1006\/exnr.1995.1088","article-title":"Neurodegeneration in the central nervous system of apoE-deficient mice.","volume":"13","author":"Roses","year":"1995","journal-title":"Exp Neurol"},{"key":"34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cmet.2007.05.010","article-title":"FGF21: a missing link in the biology of fasting.","volume":"5","author":"Reitman","year":"2007","journal-title":"Cell Metab"},{"key":"35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs.","volume":"5","author":"Moller","year":"2002","journal-title":"Annu Rev Med"},{"key":"36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1528-1167.2008.01855.x","article-title":"Neuroprotective effects of the ketogenic diet.","volume":"4","author":"Choi","year":"2008","journal-title":"Epilepsia"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2010.10.006","article-title":"Dietary ketosis enhances memory in mild cognitive impairment.","volume":"3","author":"Clegg","year":"2012","journal-title":"Neurobiol Aging"},{"key":"38","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1517\/14728222.2011.594043","article-title":"Nuclear receptors as therapeutic targets for Alzheimer\u2019s disease.","volume":"1","author":"Landreth","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/mp.2013.192","article-title":"FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.","volume":"2","author":"Chuang","year":"2015","journal-title":"Mol Psychiatry"},{"key":"40","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3249","article-title":"FGF21 regulates metabolism and circadian behavior by acting on the nervous system.","volume":"1","author":"Kliewer","year":"2013","journal-title":"Nat Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance.","volume":"5","author":"Sinclair","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.","volume":"1","author":"Hardie","year":"2005","journal-title":"Cell Metab"},{"key":"43","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/426620a","article-title":"Genetics: influence of TOR kinase on lifespan in C. elegans.","volume":"42","author":"M\u00fcller","year":"2003","journal-title":"Nature"},{"key":"44","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/acel.12057","article-title":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer\u2019s disease and other tauopathies.","volume":"1","author":"Oddo","year":"2013","journal-title":"Aging Cell"},{"key":"45","first-page":"84","article-title":"Rapamycin, Autophagy, and Alzheimer\u2019s Disease.","volume":"1","author":"Yan","year":"2013","journal-title":"J Biochem Pharmacol Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.brainresbull.2015.06.004","article-title":"Effect of caloric restriction on the SIRT1\/mTOR signaling pathways in senile mice.","volume":"11","author":"Wang","year":"2015","journal-title":"Brain Res Bull"},{"key":"47","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/jnr.22725","article-title":"Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling.","volume":"8","author":"Zhao","year":"2011","journal-title":"J Neurosci Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"353","DOI":"10.18632\/aging.100162","article-title":"SIRT1 reduces endothelial activation without affecting vascular function in ApoE-\/- mice.","volume":"2","author":"Matter","year":"2010","journal-title":"Aging (Albany NY)"},{"key":"49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.18632\/aging.100075","article-title":"Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle.","volume":"1","author":"Tong","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"50","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","article-title":"Mechanisms underlying the rapid peroxisome proliferator-activated receptor-\u03b3-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer\u2019s disease.","volume":"3","author":"Landreth","year":"2012","journal-title":"J Neurosci"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T12:32:09Z","timestamp":1599049929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11,30]]}},"alternative-id":["101086","27902456"],"URL":"https:\/\/doi.org\/10.18632\/aging.101086","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727054843.793534772","asserted-by":"object"}]},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]}}}